Literature DB >> 26823834

Association of RNF43 with cell cycle proteins involved in p53 pathway.

Haiyang Xie1, Chunyang Xing1, Guoqiang Cao1, Bajin Wei2, Xiao Xu1, Penghong Song1, Leiming Chen1, Hai Chen1, Shengyong Yin1, Lin Zhou1, Shusen Zheng1.   

Abstract

Our previous study has demonstrated that RNF43 could regulate the cell cycle in a p53-dependent manner in HCC. In this study, we aimed to access whether RNF43 could interact with cell cycle proteins involved in p53 pathway, including pRB, Cyclin D1 and MDM2. Totally, 123 paired HCC tissues and corresponding noncancerous tissues from HCC patients were included, and the expression of Cyclin D1, pRB and MDM2 was analyzed using tissue microarray. Our results showed the expression level of RNF43 in HCC was positively correlated with that of MDM2, Cyclin D1 and pRB-S780. There was no significant correlation between the expression of RNF43 and pRB-S807/S811. Indicating that RNF43 effected cell cycling by regulating the expression of pRB, Cyclin D1 and MDM2 proteins, and pRB-S780 but not pRB-S807/S811, was participated in RNF43 regulated cell cycling.

Entities:  

Keywords:  HCC; RNF43; cell cycling; p53; tissue microarray

Mesh:

Substances:

Year:  2015        PMID: 26823834      PMCID: PMC4713620     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  23 in total

Review 1.  The p53-Mdm2 module and the ubiquitin system.

Authors:  Dan Michael; Moshe Oren
Journal:  Semin Cancer Biol       Date:  2003-02       Impact factor: 15.707

Review 2.  APC/C and SCF: controlling each other and the cell cycle.

Authors:  Hartmut C Vodermaier
Journal:  Curr Biol       Date:  2004-09-21       Impact factor: 10.834

Review 3.  Transcriptional control of human p53-regulated genes.

Authors:  Todd Riley; Eduardo Sontag; Patricia Chen; Arnold Levine
Journal:  Nat Rev Mol Cell Biol       Date:  2008-05       Impact factor: 94.444

Review 4.  Retinoblastoma tumor suppressor: where cancer meets the cell cycle.

Authors:  Erik S Knudsen; Karen E Knudsen
Journal:  Exp Biol Med (Maywood)       Date:  2006-07

5.  The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.

Authors:  M Kitagawa; H Higashi; H K Jung; I Suzuki-Takahashi; M Ikeda; K Tamai; J Kato; K Segawa; E Yoshida; S Nishimura; Y Taya
Journal:  EMBO J       Date:  1996-12-16       Impact factor: 11.598

Review 6.  The p53 tumor suppressor: a master regulator of diverse cellular processes and therapeutic target in cancer.

Authors:  Marianne Farnebo; Vladimir J N Bykov; Klas G Wiman
Journal:  Biochem Biophys Res Commun       Date:  2010-05-21       Impact factor: 3.575

Review 7.  The tumor suppressor p53: cancer and aging.

Authors:  Zhaohui Feng; Wenwei Hu; Gunaretnam Rajagopal; Arnold J Levine
Journal:  Cell Cycle       Date:  2008-01-23       Impact factor: 4.534

8.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

Authors:  D Malkin; F P Li; L C Strong; J F Fraumeni; C E Nelson; D H Kim; J Kassel; M A Gryka; F Z Bischoff; M A Tainsky
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

9.  Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism.

Authors:  M B Datto; Y Li; J F Panus; D J Howe; Y Xiong; X F Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

10.  p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF-kappaB subunit with histone deacetylase 1.

Authors:  Sonia Rocha; Anthea M Martin; David W Meek; Neil D Perkins
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

View more
  2 in total

1.  Commonly observed RNF43 mutations retain functionality in attenuating Wnt/β-catenin signaling and unlikely confer Wnt-dependency onto colorectal cancers.

Authors:  Shan Li; Marla Lavrijsen; Aron Bakker; Marcin Magierowski; Katarzyna Magierowska; Pengyu Liu; Wenhui Wang; Maikel P Peppelenbosch; Ron Smits
Journal:  Oncogene       Date:  2020-02-26       Impact factor: 9.867

2.  A phospho-switch controls RNF43-mediated degradation of Wnt receptors to suppress tumorigenesis.

Authors:  Tadasuke Tsukiyama; Juqi Zou; Jihoon Kim; Shohei Ogamino; Yuki Shino; Takamasa Masuda; Alessandra Merenda; Masaki Matsumoto; Yoichiro Fujioka; Tomonori Hirose; Sayuri Terai; Hidehisa Takahashi; Tohru Ishitani; Keiichi I Nakayama; Yusuke Ohba; Bon-Kyoung Koo; Shigetsugu Hatakeyama
Journal:  Nat Commun       Date:  2020-09-15       Impact factor: 14.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.